News & Events
-
November 16, 2017
FDA CDER Regulatory Science: The Importance of Partnership and Consortia
Dr. Janet Woodcock, Director of the Center for Drug Evaluation and Research within the United States Food and Drug Administration, explains how the FDA works with academic researchers, pharmaceutical companies, and other healthcare organizations to help identify scientific gaps in drug development. Find out how these partnerships and consortia improve FDA’s ability to review drugs....... -
February 28, 2017
Considerations for Requiring Subjects to Respond to PRO Instruments Collected Electronically
This webinar provides an overview of specific considerations related to allowing subjects to opt out of responding to individual items when PRO data collection is electronic as well as the relevance to other types of electronic clinical outcome assessments. Presenter: Paul O’Donohoe, MS (CRF Health)... -
February 28, 2017
Considerations for Requiring Subjects to Respond to PRO Instruments Collected Electronically
This webinar provides an overview of specific considerations related to allowing subjects to opt out of responding to individual items when PRO data collection is electronic as well as the relevance to other types of electronic clinical outcome assessments. Presenters: Paul O’Donohoe, MS (CRF Health) and Sonya Eremenco, MA (C-Path) PDF version... -
February 24, 2017
Biomarker Qualification: Collaboration, Strategy, and Implementation
Biomarker Qualification: Collaboration, Strategy, and Implementation Webinar February 24th, 2017 Presenter: John Michael Sauer, PhD... -
January 31, 2017
Highlights from the 02 August CDISC Strategy Session
The CDISC Strategy Session highlight video includes an interview with Cheryl Fitzer-Attas (CHDI Foundation) discussing the importance of data standards to Huntington’s disease research and the new Huntington’s Disease Regulatory Science Consortium (HD-RSC), a collaboration between C-Path and CHDI....